JP2010520183A5 - - Google Patents

Download PDF

Info

Publication number
JP2010520183A5
JP2010520183A5 JP2009551253A JP2009551253A JP2010520183A5 JP 2010520183 A5 JP2010520183 A5 JP 2010520183A5 JP 2009551253 A JP2009551253 A JP 2009551253A JP 2009551253 A JP2009551253 A JP 2009551253A JP 2010520183 A5 JP2010520183 A5 JP 2010520183A5
Authority
JP
Japan
Prior art keywords
buprenorphine
naltrexone
patient
composition
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009551253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010520183A (ja
JP5577101B2 (ja
Filing date
Publication date
Priority claimed from GB0703966A external-priority patent/GB2447014A/en
Application filed filed Critical
Publication of JP2010520183A publication Critical patent/JP2010520183A/ja
Publication of JP2010520183A5 publication Critical patent/JP2010520183A5/ja
Application granted granted Critical
Publication of JP5577101B2 publication Critical patent/JP5577101B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009551253A 2007-03-01 2008-02-15 ブプレノルフィンとナルトレキソンを含む改良医薬組成物 Expired - Fee Related JP5577101B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0703966.2 2007-03-01
GB0703966A GB2447014A (en) 2007-03-01 2007-03-01 Analgesic composition comprising a specific ratio of buprenorphine and naltrexone
PCT/GB2008/000521 WO2008104735A1 (en) 2007-03-01 2008-02-15 Improved medicinal compositions comprising buprenorphine and naltrexone

Publications (3)

Publication Number Publication Date
JP2010520183A JP2010520183A (ja) 2010-06-10
JP2010520183A5 true JP2010520183A5 (enExample) 2011-04-07
JP5577101B2 JP5577101B2 (ja) 2014-08-20

Family

ID=37965733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009551253A Expired - Fee Related JP5577101B2 (ja) 2007-03-01 2008-02-15 ブプレノルフィンとナルトレキソンを含む改良医薬組成物

Country Status (21)

Country Link
US (1) US8912211B2 (enExample)
EP (1) EP2125019B1 (enExample)
JP (1) JP5577101B2 (enExample)
KR (1) KR20090115861A (enExample)
CN (1) CN101622014A (enExample)
AR (1) AR065580A1 (enExample)
AU (1) AU2008220620A1 (enExample)
BR (1) BRPI0807902A2 (enExample)
CA (1) CA2678481C (enExample)
CL (1) CL2008000608A1 (enExample)
DK (1) DK2125019T3 (enExample)
ES (1) ES2475734T3 (enExample)
GB (1) GB2447014A (enExample)
HR (1) HRP20140592T1 (enExample)
MX (1) MX2009009132A (enExample)
PE (1) PE20081799A1 (enExample)
PL (1) PL2125019T3 (enExample)
PT (1) PT2125019E (enExample)
TW (1) TW200836737A (enExample)
WO (1) WO2008104735A1 (enExample)
ZA (1) ZA200905689B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9205081B2 (en) 2010-04-29 2015-12-08 Allodynic Therapeutics, Llc Combinations of opiod/TLR4 antagonist and a cyclooxygenase (COX) inhibitor for use in the treatment of pain
US9095548B2 (en) 2010-04-29 2015-08-04 Allodynic Therapeutics, Llc Combinations of opioid/TLR4 antagonists and acetyl-para-aminophenol (APAP) for use in the treatment of pain
CA2810356C (en) * 2010-09-21 2016-06-14 Purdue Pharma L.P. Buprenorphine analogs
CA2942641A1 (en) * 2013-03-13 2014-10-02 Allodynic Therapeutics, Llc Compositions to reduce pain comprising an opioid/toll-like receptor 4 antagonist, dextro enantiomers thereof, and methods of use therefor
ES2703623T3 (es) * 2013-06-28 2019-03-11 Purdue Pharma Lp Antagonistas opioides para uso en el tratamiento de una arritmia inducida por analgésicos opioides
EP3043777B1 (en) 2013-09-10 2020-04-22 Fresh Cut Development, LLC Sublingual buprenorphine spray
US9867818B2 (en) 2013-09-10 2018-01-16 Insys Development Company, Inc. Sublingual buprenorphine spray
US9918981B2 (en) 2013-09-10 2018-03-20 Insys Development Company, Inc. Liquid buprenorphine formulations
US9839611B2 (en) 2013-09-10 2017-12-12 Insys Development Company, Inc. Sublingual buprenorphine spray
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
WO2016007245A1 (en) 2014-07-08 2016-01-14 Insys Pharma, Inc. Sublingual naloxone spray
WO2018081792A2 (en) 2016-10-31 2018-05-03 Allodynic Therapeutics, Llc Combinations of opioid/tlr4 antagonists and acetaminophen for use in the treatment of emotional pain and insomnia
US11752143B2 (en) 2020-12-31 2023-09-12 Soin Therapeutics Llc Methods of using low dose naltrexone to treat chronic pain
US12343340B2 (en) 2020-12-31 2025-07-01 Soin Therapeutics Llc Methods of using low dose naltrexone to treat chronic pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US572149A (en) * 1896-12-01 Tobacco-cutting machine
GB8430346D0 (en) 1984-11-30 1985-01-09 Reckitt & Colmann Prod Ltd Analgesic compositions
GB8728294D0 (en) * 1987-12-03 1988-01-06 Reckitt & Colmann Prod Ltd Treatment compositions
US5272149A (en) * 1992-05-05 1993-12-21 Stalling Reginald W Symptom controlled receptor substitution for addiction withdrawl
US6096756A (en) * 1992-09-21 2000-08-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
CN1204890C (zh) * 1997-12-22 2005-06-08 欧罗赛铁克股份有限公司 防止阿片样物质滥用的方法
AR031682A1 (es) 1999-11-19 2003-10-01 Reckitt Benckiser Helthcare Uk Composiciones farmaceuticas
AU776666B2 (en) * 2000-02-08 2004-09-16 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
US20050191340A1 (en) * 2002-08-09 2005-09-01 Gruenenthal Gmbh Opioid-receptor antagonists in transdermal systems having buprenorphine

Similar Documents

Publication Publication Date Title
JP2010520186A5 (enExample)
MX2009009131A (es) Mejoras en y con relacion a composiciones medicinales.
MX2009009132A (es) Composiciones medicinales mejoradas que comprenden buprenorfina y naltrexona.
JP2003514013A5 (enExample)
JP2010520185A5 (enExample)
JP2010520184A5 (enExample)
JP2009544619A5 (enExample)
JP2009536147A5 (enExample)
RU2002116361A (ru) Анальгезирующие композиции, содержащие бупренорфин
MX2009002314A (es) Composiciones farmaceuticas que comprenden hgh para suministro oral.
JP2010535805A5 (enExample)
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
WO2012007159A3 (en) Novel gastro-retentive dosage forms
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
WO2007098479A3 (en) Localized insulin delivery for bone healing
MX2011013201A (es) Composiciones para tratar adiccion a drogas y para mejorar comportamiento relacionado a la adiccion.
WO2008011426A3 (en) Methods and medicaments for administration of ibuprofen
US6271240B1 (en) Methods for improved regulation of endogenous dopamine in prolonged treatment of opioid addicted individuals
MX2009009134A (es) Composiciones medicinales mejoradas que comprenden buprenorfina y nalmefeno.
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
NZ613291A (en) Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
WO2011074015A3 (en) Composition of pharmaceutical product to treat sexual dysfunction
WO2008025790A3 (en) Use of opioid formulations in needle-less drug delivery devices
CN101068571A (zh) 改善透粘膜给药制剂的吸收的方法
NZ719087A (en) Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome